Medical technologies, biotechnology and pharmaceuticals

Melbourne's collaborative culture brings together hundreds of leading researchers and clinicians – locally and globally – focused on transforming cancer research and treatment.

Victoria is home to several significant centres and collaborations that bring together the best of cancer care, research and education:

• The Victorian Comprehensive Cancer Centre was established with Victorian Government support. It brings together the world-recognised Peter MacCallum Cancer Centre, the University of Melbourne and other key partners in a new A$1 billion purpose-built facility in Melbourne's Parkville Biomedical Precinct.
• The Olivia Newton-John Cancer Wellness and Research Centre is dedicated to providing high-quality medical treatment and supportive care for cancer patients and their families. Its programs include tumour targeting and cancer immunobiology. It is an international leader in first-in-man cancer trials, with dedicated cancer clinical trial facilities, in-house GMP facilities and PET tracer development programs.
• The Monash Partners Comprehensive Cancer Consortium is an affiliation of major academic research institutions and cancer service. Research capabilities include the Hudson Institute of Medical Research's Centre for Cancer Research which investigates the molecular mechanisms underlying the development, growth and metastasis of tumours, as well as the relationship between the innate immune system and cancer.

Melbourne’s cancer research capabilities have been pivotal in the development of several new anti-cancer drugs such as AbbVie’s VENCLEXTA™, which was based on original research discoveries at the Walter and Eliza Hall Institute (WEHI). Together with AbbVie and Genentech, WEHI developed a drug development program, progressing to its first clinical trials being conducted at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre.